|Bid||2,290.05 x 0|
|Ask||0.00 x 0|
|Day's range||2,264.65 - 2,409.50|
|52-week range||608.00 - 2,409.50|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||716.12|
|Earnings date||26-Oct-2020 - 30-Oct-2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||2,422.50|
New Delhi, Jun 28 (PTI) Piramal Enterprises on Monday said it will raise up to Rs 1,000 crore through issuance of non-convertible debentures (NCDs) on private placement basis.
New Delhi, Jun 23 (PTI) Piramal Enterprises on Wednesday said its subsidiary, Piramal Pharma, has completed the acquisition of Hemmo Pharmaceuticals.
New Delhi, Jun 8 (PTI) Shares of Piramal Enterprises on Tuesday zoomed over 10 per cent after the National Company Law Tribunal (NCLT) gave its approval to Piramal Group's bid for bankrupt-DHFL, subject to certain conditions.